Procept BioRobotics Corp (NASDAQ:PRCT)’s traded shares stood at 0.49 million during the latest session, with the company’s beta value hitting 1.03. At the last check today, the stock’s price was $80.92, to imply a decrease of -3.02% or -$2.52 in intraday trading. The PRCT share’s 52-week high remains $85.81, putting it -6.04% down since that peak but still an impressive 69.32% since price per share fell to its 52-week low of $24.83. The company has a valuation of $4.20B, with an average of 0.87 million shares in intraday trading volume over the past 10 days and average of 657.02K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Procept BioRobotics Corp (PRCT), translating to a mean rating of 1.22. Of 2 analyst(s) looking at the stock, 0 analyst(s) give PRCT a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.49.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Procept BioRobotics Corp (NASDAQ:PRCT) trade information
After registering a -3.02% downside in the latest session, Procept BioRobotics Corp (PRCT) has traded red over the past five days. The 5-day price performance for the stock is 28.45%, and 19.97% over 30 days. With these gigs, the year-to-date price performance is 93.08%. Short interest in Procept BioRobotics Corp (NASDAQ:PRCT) saw shorts transact 5.23 million shares and set a 9.57 days time to cover.
The extremes give us $49 and $79 for target low and target high price respectively. As such, PRCT has been trading 2.37% off suggested target high and 39.45% from its likely low.
Procept BioRobotics Corp (PRCT) estimates and forecasts
Looking at statistics comparing Procept BioRobotics Corp share performance against respective industry, we note that the company has outperformed competitors. Procept BioRobotics Corp (PRCT) shares are 64.61% up over the last 6 months, with its year-to-date growth rate higher than industry average at 16.07% against 12.10%. Revenue is forecast to grow 3.90% this quarter before jumping 27.80% for the next one. The rating firms project that company’s revenue will grow 59.10% compared to the previous financial year.
Revenue forecast for the current quarter as set by 8 analysts is 53.35M. Meanwhile, for the current quarter, a total of 8 analyst(s) estimate revenue growth to 65.91M.Earnings reports from the last fiscal year show that sales brought in 35.1M and 43.58M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 52.00% before jumping 51.20% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -23.27% for the past 5-year period. While 2024 is set for a 15.77% return in earnings, projections for the next 5 years are at 21.80% annually.
PRCT Dividends
Procept BioRobotics Corp has its next earnings report out on 2024-Oct-30. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Procept BioRobotics Corp (NASDAQ:PRCT)’s Major holders
Procept BioRobotics Corp insiders hold 5.00% of total outstanding shares, with institutional holders owning 87.88% of the shares at 92.51% float percentage. In total, 87.88% institutions holds shares in the company, led by FMR LLC. As of 2024-06-30, the company held over 7.29 million shares (or 14.2907% of shares), all amounting to roughly $445.33 million.
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 4.71 million shares, or about 9.2375% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $287.87 million.
We also have Vanguard Total Stock Market Index Fund and Fidelity Growth Company Fund as the top two Mutual Funds with the largest holdings of the Procept BioRobotics Corp (PRCT) shares. Going by data provided on Mar 31, 2024 , Vanguard Total Stock Market Index Fund holds roughly 1.35 shares. This is just over 2.59% of the total shares, with a market valuation of $108.66 million. Data from the same date shows that the other fund manager holds a little less at 1.24, or 2.39% of the shares, all valued at about 100.06 million.
